ITCSX
Price
$29.39
Change
-$0.22 (-0.74%)
Updated
Jun 13 closing price
Net Assets
6.69B
RLBGX
Price
$35.65
Change
-$0.31 (-0.86%)
Updated
Jun 13 closing price
Net Assets
244.39B
Interact to see
Advertisement

ITCSX vs RLBGX

Header iconITCSX vs RLBGX Comparison
Open Charts ITCSX vs RLBGXBanner chart's image
VY® T. Rowe Price Capital Apprec S
Price$29.39
Change-$0.22 (-0.74%)
VolumeN/A
Net Assets6.69B
American Funds American Balanced R6
Price$35.65
Change-$0.31 (-0.86%)
VolumeN/A
Net Assets244.39B
ITCSX vs RLBGX Comparison Chart
Loading...
View a ticker or compare two or three
VS
ITCSX vs. RLBGX commentary
Jun 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ITCSX is a Buy and RLBGX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBGX has more cash in the bank: 244B vs. ITCSX (6.69B). ITCSX pays higher dividends than RLBGX: ITCSX (2.44) vs RLBGX (2.23). ITCSX was incepted earlier than RLBGX: ITCSX (36 years) vs RLBGX (16 years). ITCSX (0.90) is less costly to investors than RLBGX (0.25). ITCSX is a more actively managed with annual turnover of: 84.00 vs. RLBGX (44.00). ITCSX has a lower initial minimum investment than RLBGX: ITCSX (0) vs RLBGX (250). ITCSX annual gain was more profitable for investors over the last year : 8.62 vs. RLBGX (5.63). RLBGX return over 5 years is better than : 40.35 vs. ITCSX (8.29).
ITCSXRLBGXITCSX / RLBGX
Total Expense Ratio0.900.25360%
Annual Report Gross Expense Ratio0.900.25360%
Fund Existence36 years16 years-
Gain YTD3.9624.59286%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets6.69B244B3%
Annual Yield % from dividends2.442.23110%
Returns for 1 year8.625.63153%
Returns for 3 years11.8433.7835%
Returns for 5 years8.2940.3521%
Returns for 10 years14.0260.8723%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CCCC1.680.06
+3.70%
C4 Therapeutics
PNTG27.67-0.07
-0.25%
Pennant Group (The)
UTHR283.35-2.79
-0.98%
United Therapeutics Corp
GSAT21.95-0.24
-1.08%
Globalstar Inc
KTTA0.79-0.04
-5.21%
Pasithea Therapeutics Corp